Data as of 4:02pm ET
| -0.09 / -0.18%|
The 3 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 53.00, with a high estimate of 57.00 and a low estimate of 48.00. The median estimate represents a +4.15% increase from the last price of 50.89.
The current consensus among 3 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.